has anyone gotten cancer from tirzepatide Key Takeaways Patients taking GLP-1 receptor agonists for weight loss had a 41% lower risk of obesity-associated cancers compared with patients prescribed diet or exercise. Patients taking had substantially greater Eli Lilly's tirzepatide has shown

Two industry experts said the FDA could add semaglutide to its "do-not-compound" list, which limits the creation of entire drug products due to safety, complexity or efficacy concerns.

(2026) FDA Federal Register (2026) WADA 2026 Prohibited List USADA

Reassess your shoe size

The analysis included only drug costs

Underwriters therefore need to continue to review and assess medical evidence for any associated side effects and potential comorbidities, including cardiovascular status, renal and hepatic function, and mental health or cognitive concerns

Individual protein needs vary based on age, activity level, kidney function, and your specific treatment plan